Cargando…

Clinicopathological Analysis of Expression of Enhancer of Zeste Homologue 2 in Canine Mammary Carcinoma

INTRODUCTION: Enhancer of zeste homologue 2 (EZH2) is the human homologue of Drosophila zeste gene enhancer. The aim of this study was to determine the expression of EZH2 in canine mammary carcinomas (CMCs) and its relationship with clinicopathological features. MATERIAL AND METHODS: The expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiaoli, Fan, Yuying, Li, Yongqi, Shi, Dongmei, Liu, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281528/ https://www.ncbi.nlm.nih.gov/pubmed/35892097 http://dx.doi.org/10.2478/jvetres-2022-0033

Ejemplares similares

Expression and significance of IL-6 and IL-8 in canine mammary gland tumors
por: Ren, Xiaoli, et al.
Publicado: (2023)

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
por: Changchien, Yi-Che, et al.
Publicado: (2012)

Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
por: Fan, Yuying, et al.
Publicado: (2021)

The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial–mesenchymal transition in resected lung adenocarcinoma
por: Matsubara, Taichi, et al.
Publicado: (2019)

Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix
por: Priya, Aditi, et al.
Publicado: (2023)

Uropathogenic E.coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2)
por: Ting, Kenneth, et al.
Publicado: (2016)

Silencing the enhancer of zeste homologue 2, Ezh2, represses axon regeneration of dorsal root ganglion neurons
por: Guo, Ting-Ting, et al.
Publicado: (2021)

Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus
por: Khattri, Michelle, et al.
Publicado: (2023)

Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
por: Fujii, Satoshi, et al.
Publicado: (2008)

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2012)

Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis
por: Martin-Mateos, Rosa, et al.
Publicado: (2018)

Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells
por: Böhm, Julian, et al.
Publicado: (2019)

MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2
por: Ai, Liang, et al.
Publicado: (2021)

Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma
por: JIA, NAN, et al.
Publicado: (2014)

The diagnostic importance of invasive micropapillary carcinoma in the canine mammary gland: clinicopathological, immunohistochemical and survival analysis
por: Gamba, Conrado O, et al.
Publicado: (2013)

Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway in vitro
por: Fan, Yuying, et al.
Publicado: (2021)

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
por: Wagener, Nina, et al.
Publicado: (2010)

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
por: Kang, Yuanyuan, et al.
Publicado: (2021)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression
por: Pinho, Salomé S, et al.
Publicado: (2007)

The Relationship between Clinicopathological Features and Expression of Epithelial and Mesenchymal Markers in Spontaneous Canine Mammary Gland Tumors
por: YOSHIDA, Kota, et al.
Publicado: (2014)

LncRNA-42060 Regulates Tamoxifen Sensitivity and Tumor Development via Regulating the miR-204-5p/SOX4 Axis in Canine Mammary Gland Tumor Cells
por: Xu, Enshuang, et al.
Publicado: (2021)

Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia
por: Hamed, Nahla A. M., et al.
Publicado: (2023)

Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
por: Lutful Kabir, Farruk M., et al.
Publicado: (2015)

Prevalence of Glomerulopathies in Canine Mammary Carcinoma
por: Crivellenti, Leandro Z., et al.
Publicado: (2016)

Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
por: Fan, Kui, et al.
Publicado: (2022)

Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
por: Hou, Tsung-Yun, et al.
Publicado: (2017)

Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas
por: Sakalauskaitė, Simona, et al.
Publicado: (2022)

Effects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer
por: Yetişir, Abdullah Evren, et al.
Publicado: (2023)

Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
por: Nakagawa, Makoto, et al.
Publicado: (2018)

Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
por: Lv, Yang-Fan, et al.
Publicado: (2015)

Gene expression profiles in canine mammary carcinomas of various grades of malignancy
por: Pawłowski, Karol M, et al.
Publicado: (2013)

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
por: Ho, Thai Huu, et al.
Publicado: (2017)

Transcriptomic Profile of Canine Mammary Ductal Carcinoma
por: Santos, Driéle B., et al.
Publicado: (2023)

E-cadherin Expression in Canine Gastric Carcinomas: Association with Clinicopathological Parameters
por: Flores, Ana R., et al.
Publicado: (2022)

Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells
por: Ma, Huarui, et al.
Publicado: (2019)

Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis
por: Cheng, Tianci, et al.
Publicado: (2018)

Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
por: Chen, Shuling, et al.
Publicado: (2015)

Enhancer of zeste acts as a major developmental regulator of Ciona intestinalis embryogenesis
por: Le Goff, Emilie, et al.
Publicado: (2015)

Targeting enhancer of zeste homolog 2 protects against acute kidney injury
por: Zhou, X., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_64a4i93110c2dv9emri4g30c04